ERBB2 and breast cancer: Suppression of FUT1 with reduced Ley expression inhibited epidermoid carcinoma (A431) and HER2-overexpressing breast cancer (NCI-N87) via EGFR19,26, and decreased adhesion of dendritic cells over endothelial cells via reduced Ley on ICAM-239.